From Our Partners
Monday, June 27, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Notable Contracts: Agentase, Combat Medical Systems

by Global Biodefense Staff
April 16, 2013

The Department of Defense this week announced several notable contract awards related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for potential applications in biodefense:

Agentase LLC, of Pittsburgh, Pa., is being awarded a $12,129,448 cost-plus-fixed-fee contract for research into a Dynamically Responsive Chemical/Biological Agent Defense System for the Defense Threat Reduction Agency in support of the research and development directorate.  Bids were solicited via BAA and multiple proposals were received.  Work will be performed in Pittsburgh, Pa., and is expected to be completed April 2018. The contracting activity is Defense Threat Reduction Agency, Ft Belvoir, Va., (HDTRA1-13-C -0003). 

Combat Medical Systems, LLC, Fayetteville, N.C., has been awarded a maximum $86,000,000 contract for ventilation, breathing equipment and related accessories.  The award is a fixed-price with economic-price-adjustment contract.  Location of performance is North Carolina with an April 14, 2018 performance completion date.  Using military services are Army, Navy, Air Force, Marine Corps, federal civilian agencies and the Veterans Administration.  Type of appropriation is fiscal 2013 Defense Working Capital funds.  The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pa. (SPM2D1-13-D-8210). 

Source: DoD Contracting

From Our Partners
Tags: AwardsBAACBRN EquipmentDefense Threat Reduction Agency

Related Posts

Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC